AI Insight
A new approach to cancer treatment focuses on analyzing the molecular and genetic characteristics of tumors rather than treating cancer based solely on where it originates in the body. This tissue-agnostic method targets specific mutations or biomarkers present in the tumor regardless of its anatomical location. Early results suggest this strategy is showing promise for patients with aggressive cancers that previously had poor prognoses.
Why it matters
This represents a fundamental shift in oncology treatment paradigms, potentially offering new therapeutic options for patients with advanced or treatment-resistant cancers. By matching treatments to tumor biology rather than tumor location, more patients may benefit from targeted therapies that were previously not considered appropriate for their cancer type.
Understand the Science
We have long treated cancer based on its location in the body. But a whole new approach that analyses tumours differently is now helping people survive forms of cancer that were once considered a death sentence
Source: A revolutionary way of targeting tumours could beat even the worst cancers